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Abstract. 
 
The spliceosomal snRNAs U1, U2, U4, and 
U5 are synthesized in the nucleus, exported to the cyto-
plasm to assemble with Sm proteins, and reimported to 
the nucleus as ribonucleoprotein particles. Recently, 
two novel proteins involved in biogenesis of small nu-
clear ribonucleoproteins (snRNPs) were identiﬁed, the 
Spinal muscular atrophy disease gene product (SMN) 
and its associated protein SIP1. It was previously re-
ported that in HeLa cells, SMN and SIP1 form discrete 
foci located next to Cajal (coiled) bodies, the so-called 
“gemini of coiled bodies” or “gems.” An intriguing fea-
ture of gems is that they do not appear to contain sn-
RNPs. Here we show that gems are present in a vari-
able but small proportion of rapidly proliferating cells 
in culture. In the vast majority of cultured cells and in 
all primary neurons analyzed, SMN and SIP1 colocalize 
precisely with snRNPs in the Cajal body. The presence 
of SMN and SIP1 in Cajal bodies is conﬁrmed by immu-
noelectron microscopy and by microinjection of anti-
bodies that interfere with the integrity of the structure. 
The association of SMN with snRNPs and coilin per-
sists during cell division, but at the end of mitosis there 
is a lag period between assembly of new Cajal bodies in 
the nucleus and detection of SMN in these structures, 
suggesting that SMN is targeted to preformed Cajal 
bodies. Finally, treatment of cells with leptomycin B (a 
drug that blocks export of U snRNAs to the cytoplasm 
and consequently import of new snRNPs into the nu-
cleus) is shown to deplete snRNPs (but not SMN or 
SIP1) from the Cajal body. This suggests that snRNPs 
ﬂow through the Cajal body during their biogenesis 
pathway.
Key words: Cajal (coiled) body • leptomycin B • nu-
cleocytoplasmic transport • SMN protein • spliceoso-
mal small nuclear ribonucleoproteins
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 nuclear ribonucleoproteins (snRNPs)
 
1
 
 are es-
sential mediators of RNA processing events. In par-
ticular, the so-called spliceosomal snRNPs play a
key role in splicing of pre-mRNA (reviewed by Burge et al.,
1999). This class includes the U1, U2, U4, U5, and U6
snRNPs. The five spliceosomal snRNAs are synthesized in
the nucleus and, with the single exception of U6 (Vankan
et al., 1990), they are rapidly exported to the cytoplasm
(Lührmann, 1988; Mattaj, 1988). The U1, U2, U4, and U5
snRNAs contain an evolutionarily conserved structural el-
ement composed of a single-stranded, uridylic acid–rich
region that is typically flanked by two hairpin loops (Bran-
lant et al., 1982). This motif binds a complex of eight pro-
teins (B, B
 
9
 
, D1, D2, D3, E, F, and G), collectively known
as the Sm or core proteins (Lührmann et al., 1990). After
assembly of the Sm core domain, the 5
 
9
 
-monomethylated
guanosine cap structure of the snRNAs is hypermeth-
ylated to yield 2,2,7-trimethylguanosine (m
 
3
 
G) (Mattaj,
1986). In addition, varying numbers of nucleotides are
trimmed from the 3
 
9
 
 end of several of the snRNAs and
many internal nucleotides are modified (Reddy and
Busch, 1988). Assembly of the Sm core, cap hypermethyla-
tion, and 3
 
9
 
 end processing occur in the cytoplasm and are
crucial for the subsequent nuclear import of the snRNP
particles (Mattaj, 1988; Izaurralde and Mattaj, 1992). The
final step in the biogenesis of these particles involves the
association of more than 30 snRNP-specific proteins that
are found in only one type of snRNP. It remains unclear
whether the assembly of these proteins takes place just be-
fore or after nuclear import. When and where the internal
snRNA modifications are introduced is also uncertain, but
a recent study by Yu et al. (1998) indicates that 2
 
9
 
-
 
O
 
-meth-
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ylation and pseudouridylation of U2 snRNA take place in
the nucleus and are required for assembly of snRNP-spe-
cific proteins.
Transport of snRNP particles from the cytoplasm to the
nucleus involves a receptor- and energy-dependent mech-
anism that is not completely understood. Both the m
 
3
 
G-
cap and a nuclear localization signal located within the Sm
core have been implicated, but not all spliceosomal sn-
RNPs have the same m
 
3
 
G-cap requirements (Fischer et al.,
1991; Michaud and Goldfarb, 1992). Differential m
 
3
 
G-cap
requirements are also detected between 
 
Xenopus 
 
oocytes
and mammalian somatic cells, presumably due to differ-
ences in soluble cytosolic factors (Marshallsay and Lühr-
mann, 1994). Competition experiments indicate that sn-
RNPs are imported by specific receptors not shared by
other classes of nuclear proteins (Fischer et al., 1991;
Michaud and Goldfarb, 1992; Izaurralde et al., 1997), and
the first nuclear import receptor for snRNPs, termed
snurportin1, was recently identified (Huber et al., 1998).
In the course of studies on heterogeneous nuclear ribo-
nucleoproteins (hnRNPs), two novel proteins involved in
snRNP biogenesis, SMN and SIP1, were discovered (Liu
and Dreyfuss, 1996; Liu et al., 1997). The SMN protein is
encoded by the Survival Motor Neurons gene, which is de-
leted or mutated in 
 
.
 
98% of patients with Spinal Muscu-
lar Atrophy (SMA), and is therefore considered the SMA
disease gene (Lefebvre et al., 1998). The SMN gene is du-
plicated in humans (Lefebvre et al., 1995), but is an essen-
tial, single-copy locus in mice (Schrank et al., 1997). SIP1
is a novel protein that forms a stable heteromeric complex
with SMN in vivo and in vitro (Liu et al., 1997). In addition
to SIP1, SMN binds to RNA (Lorson and Androphy, 1998;
Bertrandy et al., 1999) and interacts directly with several
snRNP Sm core proteins forming a large SMN-SIP1–
snRNP complex (Liu et al., 1997). Importantly, microin-
jection of anti–SIP1 antibodies in the cytoplasm of 
 
Xeno-
pus
 
 oocytes completely inhibited the Sm core assembly on
U1 and U5 snRNAs and, consequently, blocked their nu-
clear import (Fischer et al., 1997). In addition to playing an
essential role in snRNP biogenesis, more recent data sug-
gest that SMN may also be involved in recycling of the nu-
clear spliceosomal snRNPs after each round of splicing
(Pellizzoni et al., 1998).
The SMN-SIP1–snRNP complexes are biochemically
detected in both the cytoplasm and the nucleus of somatic
cells, and immunolocalization studies revealed SMN and
SIP1 proteins concentrated in novel nuclear structures
that were called “gemini of coiled bodies” or “gems” (Liu
and Dreyfuss, 1996; Liu et al., 1997) because they are fre-
quently located in close proximity to coiled bodies, a sub-
nuclear structure that is highly enriched in snRNPs (for re-
cent reviews see Lamond and Earnshaw, 1998; Matera,
1999).
Coiled bodies were first described as accessory bodies of
the nucleolus (Ramón y Cajal, 1903), and later rediscov-
ered by electron microscopists (Hardin et al., 1969; Mon-
neron and Bernhard, 1969; Hervás et al., 1980). The name
“coiled body” was introduced because when this subnu-
clear structure is viewed with the electron microscope it
resembles a tangle of coiled threads (Monneron and Bern-
hard, 1969). At present, coiled bodies have been renamed
Cajal bodies (Gall et al., 1999) and are known to contain
 
three major classes of small nuclear ribonucleoproteins.
These are the spliceosomal U1, U2, U4, U5, and U6 sn-
RNPs (Carmo-Fonseca et al., 1991, 1992; Huang and Spec-
tor, 1992; Matera and Ward, 1993), the U7 snRNA re-
quired for 3
 
9
 
 end processing of histone mRNA (Wu and
Gall, 1993; Frey and Matera, 1995; Wu et al., 1996), and
the U3 and U8 small nucleolar RNAs (snoRNAs) in-
volved in processing of pre–rRNA (Wu et al., 1993;
Jiménez-Garcia et al., 1994; Bauer et al., 1994). Although
the function of the Cajal body is still unknown, some of
these structures are located near the replicative histone
gene cluster (Gall et al., 1981; Frey and Matera, 1995),
where they may recruit histone processing factors to the
sites of histone pre–mRNA transcription (Bellini and Gall,
1998; Abbott et al., 1999). In addition, Cajal bodies associ-
ate with the human U3 snoRNA genes (Gao et al., 1997),
and with the tandemly repeated human U1 and U2 sn-
RNA genes (Frey and Matera, 1995; Smith et al., 1995).
Remarkably, the association with U2 genes requires tran-
scriptionally competent loci, indicating that targeting of
the body to this chromosomal site is mediated by nascent
snRNAs (Frey et al., 1999).
The discovery that SMN and SIP1, two proteins essen-
tial for snRNP biogenesis, are located in close proximity to
the Cajal body represented a major breakthrough in un-
raveling the function of this structure. However, an in-
triguing question was how SMN plays a direct role in nu-
clear snRNP metabolism when it is concentrated in gems,
which do not contain snRNPs under physiologic condi-
tions (see Dietz, 1998). In the present work, we demon-
strate that SMN and SIP1 are normally located in the Ca-
jal body, whereas gems are only detected in a variable but
small proportion of rapidly proliferating cells in culture.
The Cajal body is shown to represent a unique intranu-
clear site specifically enriched in snRNPs, SMN, and SIP1,
thus suggesting a direct involvement of this structure in
the snRNP biogenesis pathway.
 
Materials and Methods
 
Cell Culture
 
HeLa cells (human epitheloid carcinoma, cervix), Huh7 cells (human
hepatoma), and WI-38 cells (human female lung diploid fibroblasts) were
grown as monolayers in minimum essential medium supplemented with
2 mM 
 
L
 
-glutamine, 50 IU/ml penicillin, 50 mg/ml streptomycin, and 10%
fetal calf serum (GIBCO BRL). Primary cultures of Schwann cells were
prepared as described by Brockes et al. (1979). In brief, sciatic nerves
were dissected from 3-d-old Sprague-Dawley rats, and mixed cultures of
Schwann cells and endoneurial fibroblasts were maintained in minimum
essential medium supplemented with 10% fetal bovine serum for 1 d. To
reduce fibroblast contamination, the culture was then incubated for 2 d in
the presence of 10
 
2
 
5
 
 M cytosine arabinose. On the fourth day, the cells
were transferred to polylysine-coated coverslips and maintained for fur-
ther 3 d in the presence of 10% fetal bovine serum, 2 
 
m
 
M forskolin, and 20
 
m
 
g/ml bovine pituitary extract.
 
Immunofluorescence and Immunoelectron Microscopy 
of Cultured Cells
 
For indirect immunofluorescence cells were grown on 10 
 
3 
 
10-mm glass
coverslips. The cells were washed twice in PBS, fixed with 3.7% formalde-
hyde (freshly prepared from paraformaldehyde) in PBS for 10 min at
room temperature, and subsequently permeabilized with 0.5% Triton
X-100 in PBS for 20 min at room temperature. Alternatively, cells were
first permeabilized with 0.5% Triton X-100 in CSK buffer (100 mM NaCl, 
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300 mM sucrose, 10 mM PIPES, 3 mM MgCl
 
2
 
, 1 mM EGTA, pH 6.8; Fey
et al., 1986) containing 0.1 mM PMSF for 1 min on ice, and subsequently
fixed with 3.7% formaldehyde in CSK buffer, for 10 min at room tempera-
ture. After fixation and permeabilization, the cells were rinsed in PBS
containing 0.05% Tween-20 (PBS-Tw), incubated for 30 min with primary
antibodies diluted in PBS, washed in PBS-Tw, and incubated for 30 min
with the appropriate secondary antibodies conjugated to fluorescein
(FITC), Texas red, or indodicarbocyanine (Cy5) (Jackson ImmunoRe-
search Laboratories, Inc.). Finally, the coverslips were mounted in
VectaShield (Vector Laboratories) and sealed with nail polish.
For immunoelectron microscopy, cells were fixed with 3.7% formalde-
hyde in PBS, 
 
z
 
20 min. First, the medium was washed twice with PBS and
the fixative was added to the culture dishes for 10 min; then, the cells
were scraped using a rubber policeman and centrifuged at 7,000 
 
g
 
 for 10
min. The cell pellets were sequentially dehydrated with continuous low-
speed stirring, in 30% methanol at 4
 
8
 
C for 5 min, 50% methanol at 4
 
8
 
C
for 5 min, 75% methanol at 
 
2
 
20
 
8
 
C for 5 min, and 90% methanol at
 
2
 
20
 
8
 
C for 30 min. This was followed by mixtures of 90% methanol/Low-
icryl K4M (1:1 and 1:2 vol/vol, for 1 h each at 
 
2
 
20
 
8
 
C). Finally, the cell
pellets were embedded in Lowicryl K4M for 24 h at 
 
2
 
20
 
8
 
C and trans-
ferred to gelatine capsules. Polymerization was induced by UV irradia-
tion for 5 d at 
 
2
 
20
 
8
 
C, followed by one more day at room temperature.
Ultrathin sections on gold grids were sequentially incubated with 0.1 M
glycine in PBS (15 min), 5% BSA in PBS (15 min), and finally the pri-
mary antibody was diluted in 1% BSA, 0.1 M glycine in PBS (1 h at room
temperature). After washing, the sections were incubated with appropri-
ate secondary antibody conjugated to either 5 or 10 nm gold particles di-
luted 1:25 in 0.1% BSA in PBS (45 min at room temperature). Finally,
the sections were washed and stained with 10% aqueous uranyl acetate.
As controls, sections were treated as described, but omitting the primary
antibody.
 
Immunocytochemistry of Rat Neurons
 
Male rats of the Sprague-Dawley strain were kept on a 12-h day/night
lighting regime with lights out at 8:00. All animals were killed by over-
dose of pentobarbital. For immunofluorescence, the rats were perfused
through the ascending aorta with 3.7% formaldehyde (freshly prepared
from paraformaldehyde) in PBS, pH 7.4, for 15 min at room tempera-
ture. Supraoptic nuclei were dissected out of 500-
 
m
 
m-thick hypotha-
lamic slices and trigeminal ganglia were removed and cut into small
fragments. These tissue fragments were washed in PBS for 1 h and indi-
vidually transferred to a drop of PBS on a siliconized slide. Then, a cov-
erslip was applied on top of the slide and the tissue was squashed by
percussion with a histologic needle. The preparation was then frozen in
dry ice and the coverslip was removed using a razor blade. The slides
with adhered neurons were sequentially dehydrated in 96% and 70%
ethanol at 4
 
8
 
C for 10 min and rinsed in PBS. Before immunostaining,
the samples were sequentially incubated with 0.5% Triton X-100 in PBS
for 10 min, 0.1 M glycine in PBS for 30 min, and 0.01% Tween 20 in
PBS for 5 min.
For immunoelectron microscopy, animals were perfused with 4% form-
aldehyde (freshly prepared from paraformaldehyde) in 0.12 M phosphate
buffer, pH 7.4. The hypothalamic supraoptic nucleus was dissected out
from brain slices and left in the same fixative for 3 h at 4
 
8
 
C, dehydrated in
increasing concentrations of methanol at 
 
2
 
20
 
8
 
C, and embedded in Lowi-
cryl K4M at 
 
2
 
20
 
8
 
C. Ultrathin sections were immunostained as described
above.
 
Microscopy and Image Processing
 
Confocal microscopy was performed with either a Zeiss laser scanning mi-
croscope LSM 410 or a BioRad MRC-1024, using excitation wavelengths
of 488 nm (for FITC), 543 nm (for Texas red), and 633 nm (for Cy5). Each
channel was recorded independently and pseudocolor images were gener-
ated and superimposed. Ultrathin sections were examined with a JEOL
CXII electron microscope operated at 80 Kv.
For quantitative analysis, images were obtained from untreated and
leptomycin B–treated cells, and double labeled with probes for U2 sn-
RNA (green staining) and coilin (red staining). Each image was decom-
posed in RGB (y
 
R 
 
5
 
 
 
red, y
 
G 
 
5
 
 
 
green) and segmented according to Fwu
and Djuriç (1996) into four classes: C
 
0
 
 5 
 
extracellular background, C
 
1
 
 5
 
intracellular background (i.e., cytoplasm and nucleoli), C
 
2
 
 5 
 
nucleoplasm,
C
 
3
 
 5 
 
Cajal bodies. The average intensities for y
 
G
 
 
 
P
 
 C
 
3
 
 (m
 
2
 
) and y
 
G
 
 
 
P
 
 C
 
2
 
(m
 
1
 
) were estimated. Finally, the ratio m
 
2
 
/m
 
1
 
 was determined.
 
Results
 
SMN Is Localized in the Cajal Body
 
Immunofluorescence microscopy using anti–SMN anti-
bodies reveals bright intranuclear foci and additional dif-
fuse cytoplasmic labeling (Fig. 1 A), as previously re-
ported by Liu and Dreyfuss (1996). Labeling of the
cytoplasm is more evident when cells are first fixed with
formaldehyde, and then permeabilized with Triton X-100,
whereas the intranuclear foci are equally stained in cells
treated with detergent either before or after fixation.
Double-labeling experiments using anti–SMN and anti-
coilin antibodies show that in some HeLa cells the SMN
protein is present in dot-like structures closely related but
distinct from Cajal (coiled) bodies (Fig. 1, B and C, ar-
row), the so-called gemini of coiled bodies or gems (Liu
and Dreyfuss, 1996). Gems are also often detected inde-
pendent from Cajal bodies (Fig. 1 C, arrowhead). Most im-
portant, gems are only visible in a small proportion of
HeLa cells (1–10%). In the vast majority of cells analyzed,
SMN colocalizes precisely with coilin (Fig. 1, D and E).
Similar results were observed in both HeLa and Huh7
cells (human cervical carcinoma and hepatoma derived
epithelial cell lines, respectively) using either anti–SMN
monoclonal antibody 2B1 (Liu and Dreyfuss, 1996), or se-
rum 95020 (Lefebvre et al., 1997) (Fig. 1, D–G). Triple-
labeling experiments using anti–SMN, anti–coilin, and
anti–Sm antibodies (Fig. 1, H–K) demonstrate that sn-
RNPs colocalize with SMN in Cajal bodies (arrows), but
not in gems.
Since colocalization studies based on computer-super-
imposed images of fluorochrome-coupled antibody label-
ing are constrained by the resolution limits of light micros-
copy, immunoelectron microscopy was also performed.
Cells were fixed in formaldehyde, embedded in Lowicryl
K4M at 
 
2
 
20
 
8
 
C, and ultrathin sections were incubated with
anti–SMN and anti–coilin antibodies. Fig. 2 depicts thin
sections through the nucleus of Huh7 cells. In Fig. 2 A, the
section was incubated with anticoilin antibody and appro-
priate secondary antibody conjugated to 10-nm gold parti-
cles. The gold particles decorate the characteristic entan-
gled threads of a Cajal body. A similar labeling pattern
(i.e., concentration of gold particles over a Cajal body) is
observed in B, which depicts a thin section incubated with
anti–SMN antibody. Fig. 2, C and D, shows Cajal bodies
simultaneously labeled by anticoilin and anti–SMN anti-
bodies (detected with 5- and 10-nm gold particles, respec-
tively). This demonstrates that SMN is present in the Cajal
body of cultured cell lines.
We next compared the localization of SMN and coilin in
primary tissue cells (Fig. 3). The study was focused on neu-
rons from either the hypothalamic supraoptic nucleus or
trigeminal ganglia, because neuronal cells contain promi-
nent Cajal bodies (Lafarga et al., 1983). A characteristic
feature of neuronal cells is that, in addition to large Cajal
bodies (Fig. 3, B and E, arrows), they contain coilin in nu-
merous small cap-like structures that form a ring around
the nucleolus (Fig. 3, B and E, arrowheads; Samtama et al.,
1996; Lafarga et al., 1998). Analysis of the subnuclear dis-
tribution of SMN and coilin in 
 
.
 
1,000 neurons revealed that
SMN localizes precisely in the Cajal body (Fig. 3, A–C, ar- 
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row), but it is not detected in the perinucleolar structures
(Fig. 3, A–C, arrowheads). Double-labeling experiments
using anticoilin antibodies and monoclonal antibody 4G3
directed against the U2 snRNP protein B
 
0
 
 (Habets et al.,
1989) confirmed that snRNPs are highly enriched in the
Cajal bodies (Fig. 3, D–F, arrow), but not in the perinucle-
olar rings (Fig. 3, D–F, arrowheads). Thus, SMN and sn-
RNPs colocalize specifically in the Cajal body.
Staining of primary Schwann cells kept in culture fur-
ther revealed localization of SMN in the Cajal body (Fig. 3
G). However, when these cells were stimulated to prolifer-
ate by addition of forskolin and pituitary factors (Brockes
et al., 1979), 
 
z
 
10–15% of the nuclei contained SMN in
gems (Fig. 3, H and I).
In conclusion, these results show that SMN may either
be present in discrete focal structures that are not enriched
in snRNPs (i.e., gems) or colocalize with snRNPs in the
Cajal body. The association of SMN with Cajal bodies is
observed in both cultured cell lines and primary neurons,
whereas gems are only detected in a small proportion
(
 
,
 
15%) of rapidly proliferating cells in culture. Although
gems tend to be more frequently detected during the G1
stage of the cell cycle (T. Carvalho, unpublished data), the
overall proportion of nuclei containing gems is variable
depending on cell type and passage number.
 
SMN Is Targeted to Preformed Cajal Bodies
 
In agreement with data from earlier studies (Ferreira et al.,
1994), remnants of Cajal bodies are visible in the cyto-
plasm of mitotic HeLa cells (Fig. 4). We have previously
reported that these mitotic Cajal bodies are labeled with
Figure 1. Localization of SMN
in human cell lines. (A) HeLa
cells were fixed in formaldehyde,
permeabilized with Triton X-100,
and immunostained with anti–
SMN monoclonal antibody 2B1.
Note the cytoplasmic labeling
with additional nuclear foci.
Staining of the cytoplasm is
more difficult to detect when
cells are extracted with deter-
gent before fixation (B–G). (B
and D) Phase contrast images of
HeLa cells with superimposed
SMN labeling produced by ei-
ther monoclonal antibody 2B1
(B, green foci) or serum 95020
(D, red foci). (C and E) The cor-
responding cells double labeled
with anticoilin antibodies. The
arrow and the arrowhead in C
indicate gems; one is adjacent to
a Cajal body (arrow), whereas
the other is independent (arrow-
head). The yellow color ob-
served in E demonstrates a pre-
cise colocalization of SMN (red
staining) and coilin (green stain-
ing). (F) Phase contrast image of
an Huh7 cell with superimposed
SMN staining (red focus); (G)
the same cell double labeled for
SMN (red staining) and coilin
(green staining); the yellow color
indicates colocalization of both
proteins in the same focus.
(H–K) HeLa cell triple labeled for SMN (H), coilin (I), and Sm (J) proteins. This experiment was performed using mouse anti–SMN
monoclonal antibody 2B1 (detected with Texas red), rabbit anticoilin serum 204.3 (detected with Cy5), and human anti–Sm autoim-
mune serum C45 (detected with FITC). Superimposition of the three images (K) reveals that SMN colocalizes with Sm in Cajal bodies
(arrows), but not in gems (red foci). Bars, 10 mm.
 
Figure 2 (continues on facing page). 
 
Localization of SMN by immunoelectron microscopy. Huh7 cells were embedded in Lowicryl, sec-
tioned, and immunogold labeled with antibodies directed against coilin (A, rabbit serum 204.3) or SMN (B, mouse monoclonal anti-
body 2B1). (C and D) 0.1 
 
m
 
m. Sections double labeled using anticoilin (5-nm gold particles) and anti–SMN (10-nm gold particles) an-
tibodies. Bars: (A and B) 0.2 
 
m
 
m; (C and D) 0.1 
 
m
 
m. 
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antibodies directed against both snRNP proteins and the
m3G cap, and by snRNA-specific antisense probes, indi-
cating that they contain assembled snRNP particles (Fer-
reira et al., 1994). Here we show that these structures are
additionally labeled by anti–SMN antibodies (Fig. 4,
A–C),  indicating that the association of SMN and snRNPs
with Cajal bodies persists during mitosis. As cells progress
from telophase to G1, Cajal bodies reappear in the nucleus
(Fig. 4 D, arrows), but SMN remains exclusively in the cy-
toplasm (Fig. 4 D, arrowheads). The presence of SMN in
Cajal bodies is detected later in G1, indicating that there is
a lag period between assembly of the Cajal body and local-
ization of SMN therein. This suggests that SMN is targeted
to preformed Cajal bodies.
To further investigate whether the Cajal body plays a
role in the intranuclear localization of SMN, microinjec-
tion experiments were performed with antibodies that
promote a specific disappearance of the Cajal body (Al-
meida et al., 1998). HeLa cells were microinjected in the
nucleus with purified anticoilin monoclonal antibodies and
allowed to incubate for 24 h. The cells were then briefly
permeabilized with Triton X-100, fixed with formalde-
hyde, and sequentially incubated with fluorescein-conju-
gated anti–mouse IgG (to detect the injected antibody),
rabbit polyclonal anti–SMN antibody 95020, and Texas
red–conjugated anti–rabbit IgG. As depicted in Fig. 5 A,
cells injected with the anticoilin monoclonal antibody
1D4-delta are devoid of Cajal bodies. Staining of these
Figure 3. Localization of SMN
in primary neurons. (A–F)
Squash preparations from rat
trigeminal ganglia were double
labeled with antibodies directed
against either SMN (A, green
staining) and coilin (B, red stain-
ing) or U2snRNP B0 (D, green
staining) and coilin (E, red stain-
ing). (C and F) Superimpositions
of red and green images. The
yellow color indicates that SMN
and B0 proteins are localized in
Cajal bodies (arrows), but not in
the perinucleolar rings (arrow-
heads). (G–I) Primary Schwann
cells from rat sciatic nerve were
kept in culture and stimulated to
proliferate by addition of forsko-
lin and pituitary extract. The
cells were double labeled with
antibodies directed against SMN
(green staining) and coilin (red
staining). Although most cells
reveal colocalization of the two
proteins (G), some (z15%) con-
tain gems that are located either
independent of or in close prox-
imity to a Cajal body (H and I,
arrows). Bars, 10 mm.
Figure 4. Localization of SMN during mitosis. HeLa cells were fixed in formaldehyde, permeabilized with Triton X-100, and double la-
beled with anti–SMN monoclonal antibody 2B1 (green staining) and anticoilin antibody (red staining). Metaphase (A), anaphase (B),
and telophase (C) cells contain foci in the cytoplasm that appear yellow, demonstrating perfect colocalization of SMN and coilin pro-
teins. In contrast, in early G1 cells (D), SMN foci persist in the cytoplasm (D, arrowhead), while Cajal bodies are already detected in the
nucleus (D, arrows). 
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cells with anti–SMN antibodies fails to reveal any intranu-
clear foci, in clear contrast with the bright staining of Cajal
bodies observed in the nucleus of noninjected cells (Fig. 5,
A and D, arrow, and B and E). As expected, Cajal bodies
are brightly stained by anti–SMN antibody in the nucleus
of cells microinjected with monoclonal antibody 5P10-pi
(Fig. 5, C and F), which does not interfere with the Cajal
body structure (Almeida et al., 1998).
To further address the role of the Cajal body in the lo-
calization of SMN, primary fibroblasts were also examined
because this type of cell is normally devoid of Cajal bodies
(Spector et al., 1992; Carmo-Fonseca et al., 1993). As
Figure 5. Cajal bodies represent a platform for colocalization of SMN and snRNPs. (A–F) HeLa cells were microinjected in the nucleus
with purified anticoilin monoclonal antibodies and allowed to incubate for 24 h. (A) The cells were incubated with fluorescein-conju-
gated anti–mouse IgG to detect the injected antibody. The arrow points to a noninjected cell; note that all injected cells are devoid of
Cajal bodies. (D) Double labeling with anti–SMN antibody does not reveal any intranuclear staining; however, the noninjected cell con-
tains SMN localized in Cajal bodies (D, arrow). (B) A field of cells that were not injected. Note that most of these cells contain SMN in
Cajal bodies (E). (C) Microinjection of monoclonal antibody 5P10-pi, which does not affect the structure of Cajal bodies. (F) In these
cells, SMN localizes in Cajal bodies. (G–J) WI-38 cells were double labeled with either anti–SMN (G) and anticoilin (H) antibodies, or
anti–SMN (I) and anti–Sm (J) antibodies. Note that gems are present in cells devoid of Cajal bodies (G and H) and that gems are not
enriched in snRNPs (I and J). Bars, 10 mm. 
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shown in Fig. 5, several fibroblasts contain SMN localized
in nuclear foci (gems), despite the absence of Cajal bodies
(Fig. 5, G and H). As observed in HeLa cells, gems in fi-
broblasts are not labeled by anti–Sm antibodies (Fig. 5, I
and J).
Taken together, these results suggest that Cajal bodies
provide a structural framework for the colocalization of
SMN and snRNPs in the nucleus.
 
SIP1 Colocalizes with SMN and snRNPs in the
Cajal Body
 
Next, we examined the distribution of SIP1, a novel pro-
tein that forms a complex with SMN (Liu et al., 1997). Im-
munolocalization studies were performed using anti–SIP1
monoclonal antibody 2E17 (Liu et al., 1997), anti–Sm, and
anticoilin antibodies. As depicted in Fig. 6, both primary
neurons and HeLa cells show a precise colocalization of
SIP1 and snRNPs in the Cajal body. The presence of SIP1
in Cajal bodies was further confirmed at the electron mi-
croscopical level (data not shown). Thus, Cajal bodies rep-
resent unique intranuclear sites where snRNPs colocalize
with SMN and SIP1.
 
Leptomycin B Affects the Intranuclear Distribution
of snRNPs
 
To investigate whether snRNPs accumulated in the Cajal
body are “in transit” from the cytoplasm, we treated HeLa
cells with leptomycin B, a drug that inhibits U snRNA ex-
port to the cytoplasm (Fornerod et al., 1997) and, conse-
quently, reimport of assembled snRNPs to the nucleus.
HeLa cells were incubated with 10, 20, or 30 nM lepto-
mycin B for 1–10 h. Although these drug concentrations
produced similar effects, at the lower doses the time of re-
sponse was longer and more variable. We therefore de-
cided to work with a concentration of 30 nM. For snRNP
detection, the cells were labeled with antibodies directed
against Sm proteins (Y12; Lerner et al., 1981), the U2 sn-
RNP-specific B
 
0
 
 protein (4G3; Habets et al., 1989), and
the m3G cap of snRNAs (R1131; Reuter et al., 1984); in
addition, in situ hybridization was performed with a U2
snRNA-specific antisense probe (Carmo-Fonseca et al.,
1991). In nontreated cells, snRNPs are highly enriched in
Cajal bodies (foci in Fig. 7), whereas after 3 h of drug
treatment, snRNPs are no longer concentrated in the Cajal
body (Fig. 7). In fact, the U2 snRNP is normally approxi-
mately threefold more concentrated in Cajal bodies than
in the nucleoplasm, but after leptomycin B treatment the
average intensity of U2 snRNP labeling in the Cajal body
is similar to that in the nucleoplasm (Fig. 8).
In addition to depleting snRNPs from the Cajal body,
leptomycin B causes a decrease in the number of Cajal
bodies per nucleus and a redistribution of coilin into the
nucleolus (Fig. 9, A–C). Since Cajal bodies are very dy-
namic structures with a high turnover rate (Rebelo et al.,
1996), leptomycin B could either stimulate the disassembly
of preexisting Cajal bodies, or inhibit the assembly of new
Cajal bodies. To specifically investigate the effect of lepto-
mycin B on the assembly of new Cajal bodies, we exam-
ined the distribution of coilin in cells that have completed
mitosis in the presence of the drug. In nontreated samples,
Cajal bodies are visible in 
 
.
 
80% of early G1 cells (these
cells are identified by the persistence of the contractile
ring connecting their cytoplasms; Fig. 9, D, E, and H). In
contrast, the vast majority of early G1 cells incubated with
leptomycin B are devoid of Cajal bodies (Fig. 9, F, G, and
H). Instead of Cajal bodies, some of these cells contain
perinucleolar patches of coilin reminiscent of what is ob-
served in neurons under physiological conditions (see Fig.
3 B). As coilin appears to shuttle from the nucleolus to the
Cajal body (Isaac et al., 1998; Lafarga et al., 1998), these
results suggest that leptomycin B interferes with the efflux
of coilin from the nucleolus. As a possible consequence,
coilin would accumulate within the nucleolus (Fig. 9 A),
becoming unavailable for assembly of new Cajal bodies.
Due to their high turnover rate (Rebelo et al., 1996), this
would lead to a progressive disappearance of Cajal bodies
from the nucleoplasm.
Staining of leptomycin-treated cells with the 2B1 and
2E17 monoclonal antibodies reveals a progressive increase
in the proportion of cells containing gems (Fig. 10, A and
Figure 6. SIP1 colocalizes with
snRNPs in the Cajal body.
Squash preparations from rat
trigeminal ganglia neurons (A–
C) and HeLa cells (D–F) were
triple labeled with anti–SIP1 (A
and D), anti–Sm (B and E), and
anticoilin (C and F) antibodies.
These experiments were per-
formed using mouse anti–SIP1
monoclonal antibody 2E17 (de-
tected with Texas red), rabbit
anticoilin serum 204.3 (detected
with Cy5), and human anti–Sm
autoimmune serum C45 (de-
tected with FITC). Bars, 10 mm. 
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B), most probably due to an effect on the normal traffick-
ing dynamics of SMN-SIP1 proteins in the nucleus. How-
ever, both SMN and SIP1 are still highly enriched in Cajal
bodies (Fig. 10 A, and data not shown), suggesting that
SMN-SIP1 complexes remain associated with Cajal bodies
in the absence of newly imported snRNPs from the cyto-
plasm. This implies that if SMN, SIP1, and snRNPs are
part of a common complex in the Cajal body, there must
be a mechanism that triggers the release of snRNPs from
this structure.
 
Discussion
 
This work reports two novel protein components of the
Cajal (coiled) body, the Survival Motor Neuron gene
product and its associated protein, SIP1. As SMN and
SIP1 play an important role in snRNP biogenesis and recy-
cling (Fischer et al., 1997; Liu et al., 1997; Pellizzoni et al.,
1998), this finding provides a direct link between the Cajal
body and snRNP metabolism.
The SMN and SIP1 proteins were previously immunolo-
calized in HeLa cells to discrete nuclear foci termed gem-
ini of coiled bodies or gems (Liu and Dreyfuss, 1996). The
data presented here indicate that gems are observed in a
variable (but small) proportion of cells in culture. In the
vast majority of cells studied, including primary neurons
directly removed from organisms, SMN and SIP1 are pres-
ent exclusively in the Cajal body and gems were never
identified. Notably, the presence of SMN in Cajal bodies
was also detected by other groups (see Matera and Frey,
1998; Matera, 1999; Sleeman and Lamond, 1999a).
A major difference between Cajal bodies and gems con-
cerns the presence or absence of snRNPs. The SMN and
SIP1 proteins colocalize with snRNPs in the Cajal body,
whereas gems do not concentrate snRNPs. This makes it
likely that Cajal bodies contain the SMN-SIP1–snRNP
complexes detected in the nuclear fraction of somatic cells
(Liu et al., 1997). As SMN and SIP1 associate with sn-
RNPs in the cytoplasm, one possibility is that the SMN-
SIP1–snRNP complex enters the nucleus and is targeted to
Figure 7. Leptomycin B alters
the intranuclear distribution of
snRNPs. HeLa cells were either
untreated (-leptomycin B) or in-
cubated with 30 nM leptomycin
B for 3 h (3h leptomycin B). Un-
treated cells were labeled for sn-
RNPs using Y12 monoclonal an-
tibody (which recognizes the B,
B9, and D peptides of the Sm
family), antibody R1131 (which
recognizes the m3G cap of the U
snRNAs), 4G3 monoclonal anti-
body (which recognizes the U2
snRNP-specific protein B0), and
an antisense riboprobe comple-
mentary to U2 snRNA. Arrows
denote high concentration of sn-
RNPs in the Cajal body. After
3 h of leptomycin B treatment,
the cells were double labeled for
snRNPs and coilin. Arrows indi-
cate the position of Cajal bodies.
Note that snRNPs are no longer
highly enriched in the Cajal
body. Bar, 10 mm. 
The Journal of Cell Biology, Volume 147, 1999 724
 
the Cajal body. The Cajal body may then represent an as-
sembly platform where snRNPs in transit from the cyto-
plasm accumulate transiently, until an as yet unidentified
stage of their maturation process is completed. Taking into
account that 2
 
9
 
-
 
O
 
-methylation and pseudouridylation of
U2 snRNA take place in the nucleus and are required for
the final assembly of snRNP-specific proteins (Yu et al.,
1998), it will be important to clarify whether snRNP com-
plexes enriched in the Cajal body contain modified sn-
RNAs. In this regard, it is important to note that the U2-
specific proteins collectively termed SF3a/SF3b (Krämer,
1996), which assemble into the splicing-competent U2 sn-
RNP 17S particle, are not detected in Cajal bodies (D.
Nesic and A. Krämer, personal communication). This ob-
servation further supports the view that snRNPs concen-
trated in the Cajal body are not yet fully mature.
Assuming that both snRNPs and SMN complexes are
constantly in motion throughout the cell and accumulate
transiently in either Cajal bodies or gems, differences in
their trafficking dynamics could account for the differ-
ences observed in their steady state nuclear distribution.
In fact, expression of a dominant-negative amino-terminal
deletion mutant of SMN (SMN
 
D
 
N27), which is thought to
block nuclear snRNP recycling, causes an accumulation of
SMN in extremely enlarged Cajal bodies (Pellizzoni et al.,
1998). Moreover, SMN contains a self-oligomerization do-
main that overlaps with the Sm-interacting domain (Lor-
son et al., 1998). This implies that SMN may either form a
complex with snRNPs (most probably localized in the Ca-
jal body) or self-oligomerize, giving rise to gems. A predic-
tion from this model is that gems should become more
Figure 8. Leptomycin B depletes snRNPs from the Cajal body.
Untreated and leptomycin B–treated cells were randomly se-
lected for image segmentation and quantification. The ICM algo-
rithm (Fwu and Djuriç, 1996) was applied to segment images into
four classes (A). The average U2 snRNA labeling intensity of
Cajal bodies (m2) and nucleoplasm (m1) was calculated for each
image and their ratio (r 5 m2/m1) was estimated (B).
Figure 9. Leptomycin B affects
the dynamics of the Cajal body.
HeLa cells were treated with 30
nM leptomycin B for 3 h and
double labeled using anticoilin
(A) and antifibrillarin (B) anti-
bodies. Note that coilin colocal-
izes with fibrillarin in intranucle-
olar foci (A, arrows). The graph
depicted in C illustrates the effect
of leptomycin B on the average
number of Cajal bodies per cell
nucleus (z150 cells were
counted at each time point;
means  6 SEM are indicated). (E
and G) Early G1 cells stained
with anticoilin antibodies; (D
and F) corresponding phase con-
trast images. The cells depicted
in D and E were untreated,
whereas the cells in F and G
were treated with leptomycin B
for 3 h. In the absence of lepto-
mycin B, Cajal bodies are seen in
.80% of early G1 cells (H). In
contrast, .95% of the cells that
complete mitosis in the presence
of leptomycin B fail to assemble
new Cajal bodies (H).Carvalho et al. The Cajal Body and snRNP Biogenesis 725
prominent after depletion of snRNPs from the Cajal body,
as indeed was observed after treatment of cells with lepto-
mycin B.
The observed depletion of snRNPs from Cajal bodies
caused by leptomycin B strongly suggests that spliceoso-
mal snRNPs newly imported from the cytoplasm travel
through the Cajal body. Leptomycin B is a cytotoxin that
interacts directly with the nuclear export receptor CRM1,
inhibiting its binding to nuclear export signals and Ran-
GTP (Fornerod et al., 1997). As a consequence, this drug
blocks the export of substrates recognized by CRM1, in-
cluding Rev (Wolff et al., 1997) and proteins containing
Rev-like leucine-rich nuclear export signals (Fornerod et al.,
1997; Fukuda et al., 1997; Ossareh-Nazari et al., 1997). Al-
though CRM1 mutations in yeast interfere with mRNA
export (Stade et al., 1997), to date leptomycin B has been
found to inhibit export of only one class of RNA in verte-
brates, the U snRNAs (Fornerod et al., 1997). As shown in
Figs. 7 and 8, 3 h after drug treatment, Cajal bodies are still
present but are no longer brightly stained by antibodies di-
rected against Sm proteins, the U2 snRNP-specific B0 pro-
tein, and the m3G cap of snRNAs, or by an antisense
probe specific for the U2 snRNA. Thus, after exposure to
leptomycin B the Cajal body fails to concentrate snRNPs.
Since leptomycin B inhibits nuclear export of U snRNAs,
the assembly of new snRNP particles in the cytoplasm and
their subsequent transport to the nucleus is also blocked.
The observed redistribution of snRNPs in the nucleus can
therefore be explained if mature snRNPs present in the
Cajal body leave the structure while new particles are
prevented from reaching it. Direct visual evidence that
snRNPs flow through the Cajal body has been recently
obtained by microinjection of fluorescently tagged U sn-
RNAs into the cytoplasm of Xenopus oocytes (Gall et al.,
1999; Narayanan et al., 1999) and expression of green fluo-
rescent protein–tagged Sm proteins in HeLa cells (Slee-
man and Lamond, 1999b). These studies revealed that
both snRNAs and snRNP proteins are first detected in Ca-
jal bodies before they start to accumulate at other nuclear
locations. 
In addition to interfering with the concentration of sn-
RNPs in the Cajal body, treatment of cells with leptomycin
B also affects the distribution of coilin in the nucleus.
Shortly after exposure to the drug, coilin is detected inside
the nucleolus while the number of Cajal bodies decreases.
Within the nucleolus, coilin colocalizes with fibrillarin in
foci that correspond to the dense fibrillar component of
the nucleolus. A similar staining pattern was previously
observed in HeLa cells labeled with an anticoilin mono-
clonal antibody (mAb-f) (Almeida et al., 1998). Remark-
ably, this antibody reacts with an epitope adjacent to a
critical serine residue (serine 202) that, when mutated to
aspartate, induces the formation of Cajal body-like struc-
tures inside the nucleolus (Lyon et al., 1997). The presence
of Cajal bodies inside the nucleolus has also been reported
in certain rare cases such as breast carcinoma cells, brown
adipocytes, and hepatocytes of hibernating dormice (Mala-
testa et al., 1994; Ochs et al., 1994). Much more frequently,
Cajal bodies are located in the vicinity of nucleoli, even
physically attached to them, seemingly emerging from the
dense fibrillar component (Ferreira and Carmo-Fonseca,
1995; Lafarga et al., 1998). Supporting this morphological
evidence, several molecules are shared by both the Cajal
body and the dense fibrillar component of the nucleolus,
namely, fibrillarin (Raska et al., 1990, 1991), NAP57 and
Nopp140 (Meier and Blobel, 1994). In particular, Nopp140
interacts with coilin and has been proposed to chaperone
the transport of molecules from the nucleolus to the Cajal
body (Isaac et al., 1998). It therefore appears that lepto-
mycin B inhibits the flow of molecules between the nucle-
olus and the Cajal body, causing a retention of coilin in the
dense fibrillar component and, consequently, a decrease in
the number of Cajal bodies.
In summary, the major conclusions from this study are,
first, that two proteins essential for snRNP biogenesis,
SMN and SIP1, are localized in the Cajal body, and, sec-
ond, that the nuclear export inhibitor leptomycin B causes
a depletion of snRNPs from the Cajal body. The first ob-
servation provides a link between Cajal bodies and snRNP
biogenesis, whereas the second indicates that the accumu-
lation of snRNPs in the Cajal body is transient. Taken to-
gether, these results suggest that snRNPs flow through the
Cajal body along their biogenesis pathway.
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